ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications

References

• BoursMJSwennenELDi VirgilioFAdenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammationPharmacol Ther2006112235840410.1016/j.pharmthera.2005.04.01316784779
   PubMed Web of Science ®Google Scholar
• BurnstockGPurine and pyrimidine receptorsCell and Mol Life Sci2007641471148310.1007/s00018-007-6497-017375261
   PubMed Web of Science ®Google Scholar
• BurnstockGPurinergic signalling: pathophysiology and therapeutic potentialKeio J Med2013623637310.2302/kjm.2013-0003-RE24067872
   PubMedGoogle Scholar
• RapaportETreatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycleJ Cell Physiol1983114327928310.1002/jcp.10411403056833403
   PubMedGoogle Scholar
• RapaportEFishmanRFGercelCGrowth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphateCancer Res1983439440244066871873
   PubMedGoogle Scholar
• BurnstockGDi VirgilioFPurinergic signalling and cancerKeio J Med201394491540
   Google Scholar
• BurnstockGKnightGECellular distribution and functions of P2 receptor subtypes in different systemsInt Rev Cytol20042403130415548415
   PubMed Web of Science ®Google Scholar
• WhiteNBurnstockGP2 receptors and cancerTRENDS Pharmacol Sci200627421121710.1016/j.tips.2006.02.00416530853
   PubMed Web of Science ®Google Scholar
• ShabbirMThompsonCJarmulowiczcMEffect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivoBJU Int2008102110811210.1111/j.1464-410X.2008.07578.x18325054
   PubMedGoogle Scholar
• HaskellCMMendozaEPistersKMPhase II study of intravenous adenosine 5′-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancerInvest New Drugs199816818510.1023/A:10060186109869740548
   PubMed Web of Science ®Google Scholar
• HaskellCMWongMWilliamsALeeLYPhase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancerMed Pediatr Oncol19962716517310.1002/(SICI)1096-911X(199609)27:3<165::AID-MPO6>3.0.CO;2-C8699994
   PubMedGoogle Scholar
• AgtereschHJDagneliePCRietveldTPharmacokinetics of intravenous ATP in cancer patientsEur J Clin Pharmacol200056495510.1007/s00228005071910853877
   PubMed Web of Science ®Google Scholar
• RapaportESalikhovaAAbrahamEHContinuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declinesPurinergic Signal201511225126210.1007/s11302-015-9450-y25917594
   PubMedGoogle Scholar
• DuYZYingXYWangLSustained release of ATP encapsulated in chitosan oligosaccharide nanoparticlesInt J Pharm20103921–216416910.1016/j.ijpharm.2010.03.05020362652
   PubMedGoogle Scholar
• GiacaloneGBochotAFattalEDrug-induced nanocarrier assembly as a strategy for the cellular delivery of nucleotides and nucleotide analoguesBiomacromolecules201314373774210.1021/bm301832v23351139
   PubMed Web of Science ®Google Scholar
• GiacaloneGHillaireauHCapiauPStabilization and cellular delivery of chitosan-polyphosphate nanoparticles by incorporation of ironJ Control Release201419421121910.1016/j.jconrel.2014.08.02225192940
   PubMed Web of Science ®Google Scholar
• ZhangLGuFXChanJMNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176910.1038/sj.clpt.610040017957183
   PubMed Web of Science ®Google Scholar
• WoodsAPatelASpinaDIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryJ Control Release20152101910.1016/j.jconrel.2015.05.26925980621
   PubMed Web of Science ®Google Scholar
• HuCMZhangLAryalSErythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProc Natl Acad Sci201110827109801098510.1073/pnas.110663410821690347
   PubMed Web of Science ®Google Scholar
• WangSZhaoJYangHBottom-up synthesis of WS2 nanosheets with synchronous surface modification for imaging guided tumor regressionActa Biomater20175844245410.1016/j.actbio.2017.06.01428611005
   PubMed Web of Science ®Google Scholar
• YangHZhaoJWuCYeCZouDWangSFacile synthesis of colloidal stable MoS2 nanoparticles for combined tumor therapyChem Engin J201835154855810.1016/j.cej.2018.06.100
   Web of Science ®Google Scholar
• ZhaoJXiePYeaCOutside-in synthesis of mesoporous silica/molybdenum disulfide nanoparticles for antitumor applicationChem Engin J201835115716810.1016/j.cej.2018.06.101
   Google Scholar
• ShuklaRSJainAZhaoZChengKIntracellular trafficking and exocytosis of a multi-component siRNA nanocomplexNanomedicine20161251323133410.1016/j.nano.2016.02.00326970028
   PubMed Web of Science ®Google Scholar
• BanksPRPaquetteDMComparison of three common amine reactive fluorescent probes used for conjugation to biomolecules by capillary zone electrophoresisBioconjug Chem1995644474587578365
   PubMed Web of Science ®Google Scholar
• JainABarveAZhaoZJinWChengKComparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA deliveryMol Pharm20171451517152710.1021/acs.molpharmaceut.6b0093328026957
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818210.1016/j.jconrel.2011.07.03121839127
   PubMed Web of Science ®Google Scholar
• LangerKBalthasarSVogelVOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm200325716918010.1016/S0378-5173(03)00134-012711172
   PubMed Web of Science ®Google Scholar
• Jahanban-EsfahlanADastmalchiSDavaranSA simple improved desolvation method for the rapid preparation of albumin nanoparticlesInt J Biol Macromol20169170370910.1016/j.ijbiomac.2016.05.03227177461
   PubMed Web of Science ®Google Scholar
• HubleyMJLockeBRMoerlandTSThe effects of temperature, pH, and magnesium on the diffusion coefficient of ATP in solutions of physiological ionic strengthBiochim Biophys Acta1996291211512110.1016/0304-4165(96)00053-0
   Google Scholar
• FernandesHPCesarCLBarjas-CastroMLElectrical properties of the red blood cell membrane and immunohematological investigationRev Bras Hematol Hemoter201133429730110.5581/1516-8484.2011008023049321
   PubMedGoogle Scholar
• AnFFZhangXHStrategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug deliveryTheranostics20177153667368910.7150/thno.1936529109768
   PubMed Web of Science ®Google Scholar
• HuCMFangRHLukBT‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approachNanoscale2013572664266810.1039/c3nr00015j23462967
   PubMed Web of Science ®Google Scholar
• Welter-StahlLDa SilvaCMSchachterJExpression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cellsBiochim Biophys Acta2009178851176118710.1016/j.bbamem.2009.03.00619306841
   PubMedGoogle Scholar
• DeliTCsernochLExtracellular ATP and cancer: an overview with special reference to P2 purinergic receptorsPathol Oncol Res200814321923110.1007/s12253-008-9071-718575829
   PubMedGoogle Scholar
• NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355710.1038/nmat244219525947
   PubMed Web of Science ®Google Scholar
• NaahidiSJafariMEdalatFRaymondKKhademhosseiniAChenPBiocompatibility of engineered nanoparticles for drug deliveryJ Control Release2013166218219410.1016/j.jconrel.2012.12.01323262199
   PubMed Web of Science ®Google Scholar
• Di VirgilioFSartiACFalzoniSDe MarchiEAdinolfiEExtracellular ATP and P2 purinergic signalling in the tumour microenvironmentNat Rev Cancer2018181060161810.1038/s41568-018-0037-030006588
   PubMed Web of Science ®Google Scholar
• ElsadekBKratzFImpact of albumin on drug delivery–new applications on the horizonJ Control Release2012157142810.1016/j.jconrel.2011.09.06921959118
   PubMed Web of Science ®Google Scholar
• KhandelwalSvan RooijenNSaxenaRKReduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulationTransfusion20074791725173210.1111/j.1537-2995.2007.01348.x17725740
   PubMedGoogle Scholar
• SalatinSMaleki DizajSYari KhosroushahiAEffect of the surface modification, size, and shape on cellular uptake of nanoparticlesCell Biol Int2015888189010.1002/cbin.10459
   Google Scholar
• ZhangYYangMPortneyNGZeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cellsBiomed Microdevices2008232132810.1007/s10544-007-9139-2
   Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562710.1038/nrd259120616808
   PubMed Web of Science ®Google Scholar
• PlesnerLEcto-ATPases: identities and functionsInt Rev Cytol19951581412147721538
   PubMed Web of Science ®Google Scholar